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Background: Numerous studies have shown inconsistent results regarding effects of concomitant use of thienopyridines and proton pump 
inhibitors (PPI) on cardiovascular outcomes.
Methods: We sought to evaluate clinical impact of comparison Histamine type-2 receptor antagonist and PPI-use in patients treated with 
thienopyridines after percutaneous coronary intervention (PCI) in a large Japanese observational database. Among 12446 patients discharged alive 
on thienopyridines (ticlopidine 90.4% and clopidogrel 9.6%), 3223 patients were treated with PPIs and 3276 patients with only H2RA and 5947 
patients with non PPIs non H2RA at the time of hospital discharge.
Results: The adjusted hazard ratio (HR) of PPI-use for a composite of cardiovascular death, myocardial infarction, and stroke was 1.26 (95% 
confidence interval (CI): 1.09-1.47, p=0.002). Those of H2RA was 1.18(95% CI: 1.01-1.37, p=0.04).The adjusted HR of PPI-use for bleeding was 
1.26 (95% CI: 1.05-1.52, p=0.013). it of H2RA was 0.83 (95% CI: 0.67-1.03, p=0.013).
Conclusions: In conclusion, cardiovascular outcomes after PCI were significantly worse in patients with PPI and H2RA than in patients neither PPI 
nor H2RA in the Japanese real clinical practice. Bleeding after PCI was significantly worse in patients with PPI, but was significantly better in patient 
H2RA than control. However, the observed poorer cardiovascular outcome in patients receiving PPI or H2RB was most likely to be related to residual 
confounding.
